Patents by Inventor Suparna Mazumder

Suparna Mazumder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OVARIAN CANCER VACCINES
    Publication number: 20240041798
    Abstract: Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).
    Type: Application
    Filed: September 7, 2023
    Publication date: February 8, 2024
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
  • Ovarian cancer vaccines
    Patent number: 11786489
    Abstract: Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: October 17, 2023
    Assignee: The Cleveland Clinic Foundation
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
  • AMHR2-ED CANCER VACCINE FORMULATIONS
    Publication number: 20230256068
    Abstract: Provided herein are compositions, systems, kits, and methods of using a composition comprising at least a portion of an Anti-Mullerian Hormone Receptor Type II extracellular domain (AMHR-ED), and an adjuvant comprising: i) squalene oil, ii) a non-ionic surfactant (e.g., Tween 80), iii) an emulsifier (e.g., sorbitan trioleate), and iv) a buffer (e.g., citrate buffer). In certain embodiments, such compositions are administered to a female subject to treat or prevent ovarian or endometrial cancer (e.g., by inducing expression of anti-AMHR2-ED IgG antibodies by the subject in vivo).
    Type: Application
    Filed: February 15, 2023
    Publication date: August 17, 2023
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
  • ANTI-MULLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE
    Publication number: 20230078601
    Abstract: Provided herein are anti-Anti-Miillerian Hormone Receptor 2 (AMHR2) antibodies and methods of using such antibodies, for example, in the treatment of cancer.
    Type: Application
    Filed: January 29, 2021
    Publication date: March 16, 2023
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
  • OVARIAN CANCER VACCINES
    Publication number: 20210379171
    Abstract: Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).
    Type: Application
    Filed: August 17, 2021
    Publication date: December 9, 2021
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
  • Ovarian cancer vaccines
    Patent number: 11090284
    Abstract: Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: August 17, 2021
    Assignee: The Cleveland Clinic Foundation
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson
  • OVARIAN CANCER VACCINES
    Publication number: 20190134173
    Abstract: Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).
    Type: Application
    Filed: September 2, 2016
    Publication date: May 9, 2019
    Inventors: Vincent K. Tuohy, Suparna Mazumder, Justin M. Johnson